（文章来源：证券日报） 证券日报网讯海尔生物11月24日在互动平台回答投资者提问时表示，积极把握产业周期，在高潜力赛道 加快布局，为用户提供多品类下的数字场景综合解决方案，是公司中长期持续发展的关键所在。当前， 公司已布局光谱类科研仪器产业，未来公司将精心挑选具有高技术壁垒和巨大发展潜力的公司，继续增 强整体竞争力。后续如有相关计划落地，公司将严格按照相关规定和要求，履行信息披露义务。 ...

格隆汇11月24日丨海尔生物(688139.SH)在投资者互动平台表示，当前，公司已布局光谱类科研仪器产 业，未来公司将精心挑选具有高技术壁垒和巨大发展潜力的公司，继续增强整体竞争力。 （原标题：海尔生物(688139.SH)：当前公司已布局光谱类科研仪器产业） ...

"对于我们来说，我们的规模性可能还体现在我们在市场上发挥的这种投资引领的作用，因为我们的投 资可以带动更多的社会资本去投入到国家最需要进行突破的领域。"薛捷表示。 (作者：赵云帆,陈泽锴编辑：朱益民) 她认为，通过这一模式，能够形成一种既能分散风险，又能获取收益的投资组合。 11月12日，上交所举办国际投资者大会。全国社保基金理事会股票投资部副主任薛捷发表了对科技股投 资的看法。 她表示，社保基金作为长期资金，有非常大的规模体量。这个规模体量，可以使我们能够系统地支持国 家战略，能够全方位全链条地进行产业布局，可以在不同领域、不同阶段布下种子。 ...

Core Viewpoint - The company intends to acquire 100% equity of Guanglong Integrated and 80% equity of Aojian Microelectronics, enhancing its market position and technological capabilities through strategic synergies [1][3]. Group 1: Acquisition Details - The company plans to purchase Guanglong Integrated and Aojian Microelectronics through a combination of share issuance and cash payment [1]. - Guanglong Integrated specializes in the research, production, and sales of passive optical devices, with products used in various fields such as optical network protection and AI computing centers [1]. - Aojian Microelectronics focuses on high-performance analog chip design, with core products in power management and signal chain categories, applicable in consumer electronics and automotive sectors [2]. Group 2: Synergies and Benefits - The acquisition is expected to create significant market, product, and technological synergies between the company and the target firms [3]. - The company’s strong distribution capabilities and customer resources will help accelerate market entry for the acquired companies [3]. - Technological collaboration will leverage the company’s expertise in optical signal conversion and MEMS technology, enhancing product offerings [3]. - The acquisition will also allow for vertical integration of the supply chain, improving production and procurement efficiencies [3]. Group 3: Funding and Future Outlook - To support the acquisition and enhance financial strength, the company plans to raise additional funds from specific investors [4]. - Successful fundraising will bolster the company’s capital, improving its risk management and supporting sustainable development [4]. - The transaction is anticipated to expand the company’s business scale and profitability, ultimately benefiting shareholders [3][4].

Group 1: Financial Performance - The company achieved a revenue of CNY 6.707 billion in the first three quarters of 2025, representing a year-on-year growth of 22.01% [2] - The net profit attributable to shareholders reached CNY 651 million, with a year-on-year increase of 21.43% [2] - The automotive parts business saw a sales revenue growth of 25% due to the overall growth in the automotive industry, with passenger car sales reaching 21.246 million units, up 13.7% year-on-year [2][3] Group 2: Automotive Parts Business Advantages - The company has a comprehensive industrial layout with over 20 production bases, enabling close and timely supply to major automotive manufacturers [3] - It possesses strong technical and R&D capabilities, holding over 500 patents and focusing on key technologies in smart cockpit and lightweight materials [3] - The company has established a stable and high-quality customer base, enhancing its brand image and market recognition [3] - A complete product series allows for integrated automotive parts services, effectively controlling production costs [3] Group 3: Oil and Gas Equipment Business - The company’s subsidiary has maintained over 30 years of collaboration with major domestic oil companies, supplying key equipment for deep-sea oil extraction [4][5] - It has achieved breakthroughs in critical technologies, such as high-temperature and high-pressure perforation, positioning itself as a leader in the domestic market [5] - The developed ultra-high temperature and pressure perforation technology has been successfully applied in 10,000-meter deep well operations, setting a global record [5] Group 4: Military Products and Future Plans - The military explosives business generated CNY 6.7338 million in revenue in the first half of 2025, reflecting a growth of 6.96% year-on-year [6] - The company plans to adjust its military explosives project to enhance production capacity and meet market demands, with expected annual revenue of CNY 150.027 million post-adjustment [6] Group 5: Market and Shareholder Relations - The company aims to enhance its core competitiveness and long-term investment value, focusing on market development and technological innovation [6] - It plans to increase cash dividends in line with regulatory requirements to reward investors [6] - The major shareholder, Lekai Group, is reducing its stake due to personal financial needs, with plans for future transactions disclosed in advance [7]

Core Viewpoint - Western Mining has successfully acquired exploration rights for the Chating copper polymetallic mine, marking a significant step in strengthening its resource reserves and expanding its industry layout [1][2]. Group 1: Acquisition Details - Western Mining's subsidiary, Tibet Yulong Copper Co., Ltd., won the exploration rights for the Chating copper polymetallic mine in Anhui Province with a bid of 8.60893 billion yuan [1]. - The exploration rights cover various minerals, including copper, lead, zinc, gold, silver, and natural sulfur [1]. Group 2: Company Overview - Western Mining is a key mining enterprise in China's western region, with a diverse portfolio that includes copper, lead, zinc, iron, and other critical minerals [2]. - The company operates across the entire mineral industry chain, including mining, smelting, and trading of various metals, as well as rare and non-metallic products [2]. Group 3: Financial Performance - In the third quarter of 2025, Western Mining reported a revenue of 48.442 billion yuan, a year-on-year increase of 31.9%, and a net profit of 2.945 billion yuan, up 7.8% [3]. - The company experienced growth in mineral production, with copper output increasing by 1.32%, zinc by 19.92%, and lead by 21.02% compared to the previous year [3]. - As of the end of the third quarter, the company had a net cash flow from operating activities of 8.81 billion yuan and cash reserves of 7.256 billion yuan [3].

Core Viewpoint - The company reported a significant decline in revenue and net profit for the third quarter of 2023, indicating potential challenges in its business operations [1] Financial Performance - Revenue for the first three quarters of 2023 was approximately 209 million yuan, a year-on-year decrease of 28.6% [1] - Net profit attributable to shareholders was about 33.11 million yuan, reflecting a year-on-year decline of 57.44% [1] - Basic earnings per share were 0.5 yuan, down 57.26% compared to the previous year [1] Business Strategy - The company is actively monitoring opportunities in the upstream and downstream industrial layout of its main business [1] - The company emphasizes strict compliance with relevant laws and regulations, asserting that there are no undisclosed significant matters [1] - The company commits to timely information disclosure regarding any significant matters that may arise in the future [1]

Core Viewpoint - The company is establishing investment funds in collaboration with professional investment institutions to strengthen its presence in the agricultural and animal husbandry sectors in Guangdong province [1] Group 1: Investment Details - The company plans to invest 59.9 million yuan (49.92% stake) in the establishment of Shaoguan Shaotang No. 1 Agricultural and Animal Husbandry Equity Investment Fund Co., Ltd. [1] - The company will also invest 59.9 million yuan (49.92% stake) in the establishment of Shaoguan Shaotang No. 2 Agricultural and Animal Husbandry Equity Investment Fund Co., Ltd. [1] - The wholly-owned subsidiary, Foshan Meishen, intends to invest 40.5 million yuan (40.5% stake) in the establishment of Guangdong Province Yuemaoshan No. 3 Private Equity Investment Fund Co., Ltd. [1] Group 2: Investment Focus - The funds will primarily target projects in the agricultural and animal husbandry sectors in regions such as Shaoguan and Maoming [1] - The collaboration aims to incubate and cultivate quality projects through partnerships with long-term capital [1] - This initiative is part of the company's strategy to solidify its industrial layout in the Guangdong region [1]

Core Viewpoint - Wanbang Pharmaceutical (301520) is actively monitoring opportunities in the upstream and downstream industrial layout of its main business, ensuring compliance with relevant laws and regulations, and confirming that there are no undisclosed significant matters [1] Summary by Categories - **Business Strategy** - The company is focused on the industrial layout opportunities related to its main business [1] - **Regulatory Compliance** - The company strictly adheres to relevant laws and regulations, indicating a commitment to transparency and governance [1] - **Disclosure Practices** - The company assures that it will fulfill its information disclosure obligations in a timely manner if any significant matters arise that require disclosure [1]

Core Viewpoint - The company has signed an investment agreement for a high-performance rare earth permanent magnet project, indicating a strategic move to enhance its production capabilities and expand its business scale [1] Group 1: Project Details - The total investment for the project is estimated at 850 million yuan, with the first phase requiring an investment of 210 million yuan [1] - The project will be constructed in two phases, with a construction period of 18 months for the first phase [1] - The project includes the establishment of manufacturing facilities, supporting infrastructure, production line equipment, and a research and development center [1] Group 2: Strategic Implications - The project is expected to improve the company's industrial layout and operational capacity [1] - Upon completion, the project will contribute to the expansion of the company's business scale [1]